New England Biolabs® Announces Agreement with AmpTec GmbH to supply key mRNA Synthesis Reagents
IPSWICH, Mass., Oct. 27, 2016 /PRNewswire/ -- New England Biolabs, Inc. (NEB®) has strengthened its position as a key supplier to the fast-growing RNA synthesis market by signing an agreement to supply critical reagents to AmpTec GmbH, a leading manufacturer of synthetic long RNAs and functional mRNAs for research, diagnostic and therapeutic applications. Under the terms of the agreement, NEB will manufacture and supply enzymes for in vitro transcription and capping of RNA.
Commenting on the relationship, AmpTec's President and CEO, Guido Krupp stated, "NEB has a long track record as leading supplier of molecular biology enzymes and associated reagents for life science research. With this agreement, the strengths of NEB and AmpTec are combined to provide the market with the highest quality RNA for projects of all scales, from micrograms to grams."
"We are pleased to formalize our relationship with AmpTec. By applying our technical and production expertise in enzyme chemistry, we can support AmpTec as a leading service provider in the RNA synthesis market," said Julie Moore, Director of Global Customized Solutions at NEB. "NEB has built an RNA synthesis product portfolio to address the market's growing needs. By working with innovative companies, such as AmpTec, we can now ensure that these technologies achieve their potential."
To learn more about NEB's product offerings in the mRNA synthesis space, download the RNA Synthesis brochure at https://www.neb.com/forms/request-literature. To inquire about NEB's custom capabilities for supplying RNA synthesis reagents, contact us at [email protected].
About New England Biolabs
Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, genome editing epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.
About AmpTec GmbH
AmpTec manufactures high quality synthetic nucleic acid products for research, diagnostic and therapeutic markets. AmpTec is ISO 13485 certified and its production facility (at present about 4,000 square feet) is compliant with FDA21 CFR part 820 (cGMP manufacturing). AmpTec's solutions help advance biomedical research with special focus on commercial applications the fields of IVD and mRNA therapeutics. Founded in 2005, AmpTec is a privately held firm based in Hamburg, Germany and employs currently 15 scientists and other professionals. For more information about the firm and products, visit their web site at www.amp-tec.com.
NEB® and NEW ENGLAND BIOLABS® are registered trademarks of New England Biolabs, Inc.
Logo - http://photos.prnewswire.com/prnh/20160907/405111LOGO
SOURCE New England Biolabs, Inc.
Share this article